People: Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

0.22AUD
6 May 2015
Change (% chg)

$-0.01 (-4.44%)
Prev Close
$0.22
Open
$0.22
Day's High
$0.22
Day's Low
$0.22
Volume
253,136
Avg. Vol
879,529
52-wk High
$0.28
52-wk Low
$0.08

Search Stocks

Summary

Name Age Since Current Position

Donal O'Dwyer

60 2004 Independent Non-Executive Chairman of the Board

Duncan Ross

55 2006 Chief Executive Officer, Managing Director, Executive Director

Peter Manley

2005 Chief Financial Officer, Company Secretary

Mark Harding

2008 Vice President, Global Marketing & International Sales – AtCor Medical Pty Ltd

Douglas Kurschinski

2008 Senior Vice President - US Commercial Operations AtCor Medical Inc.

Michael O'Rourke

76 Non-Executive Director

David Brookes

2008 Independent Non-Executive Director

Peter Jenkins

78 2004 Independent Non-Executive Director

Biographies

Name Description

Donal O'Dwyer

Mr. Donal O'Dwyer, BEng, MBA, serves as Independent Non-Executive Chairman of the Board of AtCor Medical Holdings Limited. He is Independent director of the Group since September 2004 and chairman since November 2004. Extensive experience in the cardiovascular sector. Prior to joining the AtCor Board he was worldwide President of Cordis Cardiology, the cardiology division of Johnson & Johnson. He is the Non-executive director for 3 other listed public companies: Cochlear Ltd, Mesoblast Ltd and Fisher & Paykel Healthcare Corporation Ltd.

Duncan Ross

Mr. Duncan R. Ross, BS serves as Chief Executive Officer, Managing Director and Executive Director of AtCor Medical Holdings Limited. He is the Executive director of the Group since November 2006. He has 29 years in life sciences and medical device industry.He is the Most recent Group President of Fisher Scientific Inc and Apogent Technologies Inc prior to joining AtCor Medical.

Peter Manley

Mr. Peter Manley CPA BBus, ACIS., serves as Chief Financial Officer and Company Secretary of AtCor Medical Holdings Limited. Peter was appointed to the position of company secretary in March 2005. He also holds the position of Chief Financial Officer. Before joining AtCor Medical Holdings Limited he was Company Secretary and CFO for Sirtex Medical Ltd, a publicly listed medical device company. Prior to this he has held financial positions in a variety of large Australian and foreign-owned corporations.

Mark Harding

Douglas Kurschinski

Mr. Douglas (Doug) Kurschinski serves as Senior Vice President - US Commercial Operations AtCor Medical Inc of AtCor Medical Holdings Limited. He joined AtCor in April 2004, and is based in AtCor’s US office in Chicago. He was previously Director, Global Clinical Operations for Stereotaxis Inc and Director of Sales with Cardiac Pathways Corp. where he helped turn the company around from financial difficulty to a sale to Boston Scientific two years later. Doug had spent the previous nine years with Guidant Corporation and St Jude Medical including senior roles in clinical research, corporate development and new product launches. Doug has a BEng (Biomedical) from the University of Iowa and an MBA from the University of Chicago.

Michael O'Rourke

Dr. Michael O'Rourke M.D., A.M., DSc, serves as Non-Executive Director of AtCor Medical Holdings Limited. He is the Co-founder and inventor of the core technology for the SphygmoCor system. Co-author of the standard reference textbook McDonald’s Blood Flow in Arteries. He also serves on the editorial Boards for the American Heart Association journal Hypertension, and on the editorial Boards of Journal of Hypertension, American Journal of Hypertension and Journal of American Society of Hypertension.

David Brookes

Dr. David L. Brookes serves as Independent Non-Executive Director of AtCor Medical Holdings Limited. He was appointed on November 2008. He is the Independent director for the Group since November 2008. he is a Fellow of the Australian College of Rural and Remote Medicine. He currently works as a general medical practitioner and has extensive experience in rural Australia, especially in paediatric and procedural practice.

Peter Jenkins

Mr. Peter Jenkins, DSc (honorary) serves as Independent Non-Executive Director of AtCor Medical Holdings Limited. He Has served on the AtCor Group’s Board since 2000, including 4 years as chairman. He is a Consultant to Colonial First State Private Equity until his retirement in December 2005. Previously he had over 30 years experience in the pharmaceutical and medical diagnostics industry.

Basic Compensation

Name Fiscal Year Total

Donal O'Dwyer

104,000

Duncan Ross

511,311

Peter Manley

270,290

Mark Harding

295,675

Douglas Kurschinski

370,619

Michael O'Rourke

25,000

David Brookes

45,000

Peter Jenkins

45,000
As Of  29 Jun 2013

Options Compensation

Search Stocks